Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK.

Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK.

OBJECTIVE: To evaluate the psychosocial impact of participation in a population-based prostate-specific antigen (PSA) testing programme, akin to screening, and to explore the relationship between urinary symptoms reported before PSA testing and the response to the subsequent PSA result. PATIENTS AN...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Brindle, L, Oliver, SE, Dedman, D, Donovan, J, Neal, D, Hamdy, F, Lane, J, Peters, T
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	2006

Ижил төстэй зүйлс

Population-based prostate-specific antigen testing in the UK leads to a stage migration of prostate cancer.
-н: Moore, A, зэрэг
Хэвлэсэн: (2009)

Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy.
-н: Avery, K, зэрэг
Хэвлэсэн: (2012)

Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy
-н: Avery, K, зэрэг
Хэвлэсэн: (2012)

Seasonal variation in prostate-specific antigen levels: A large cross-sectional study of men in the UK
-н: Down, L, зэрэг
Хэвлэсэн: (2011)

Seasonal variation in prostate-specific antigen levels: a large cross-sectional study of men in the UK.
-н: Down, L, зэрэг
Хэвлэсэн: (2011)

Prostate Testing for Cancer and Treatment (ProtecT) feasibility study
-н: J. Donovan, зэрэг
Хэвлэсэн: (2003-01-01)

Prostate cancer detection in men aged 45-49 years in the UK protect (prostate testing for cancer and treatment) trial
-н: Hamdy, F, зэрэг
Хэвлэсэн: (2006)

Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study
-н: Young, GJ, зэрэг
Хэвлэсэн: (2017)

The protecT (prostate testing for cancer and treatment) study: Evaluating screening and treatment of clinically localised prostate cancer in the UK
-н: Hamdy, F, зэрэг
Хэвлэсэн: (2006)

Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?
-н: Macefield, R, зэрэг
Хэвлэсэн: (2009)

The value of repeat serum PSA measurements in the detection of prostate cancer - Experience from the feasibility phase of the UK protect study
-н: Hamdy, F, зэрэг
Хэвлэсэн: (2006)

Prostate-specific antigen testing and prostate biopsy: are self-reported lower urinary tract symptoms and health-related quality of life associated with the decision to undergo these investigations?
-н: Avery, K, зэрэг
Хэвлэсэн: (2008)

Serum insulin-like growth factor-I is positively associated with serum prostate-specific antigen in middle-aged men without evidence of prostate cancer.
-н: Oliver, SE, зэрэг
Хэвлэсэн: (2004)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study
-н: Rosario, D, зэрэг
Хэвлэсэн: (2012)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study.
-н: Rosario, D, зэрэг
Хэвлэсэн: (2012)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: Prospective evaluation within ProtecT study
-н: Rosario, D, зэрэг
Хэвлэсэн: (2012)

Prostate-specific antigen testing rates remain low in UK general practice: a cross-sectional study in six English cities.
-н: Williams, N, зэрэг
Хэвлэсэн: (2011)

Prostate-specific antigen testing rates remain low in UK general practice: A cross-sectional study in six English cities
-н: Williams, N, зэрэг
Хэвлэсэн: (2011)

The protect (prostate testing for cancer and treatment) study: Advanced cases found through a UK screening study
-н: Neal, D, зэрэг
Хэвлэсэн: (2006)

Contribution of a single repeat PSA test to prostate cancer risk assessment: experience from the ProtecT study.
-н: Rosario, D, зэрэг
Хэвлэсэн: (2008)

Longitudinal prostate-specific antigen reference ranges: Choosing the underlying model of age-related changes
-н: Simpkin, A, зэрэг
Хэвлэсэн: (2013)

ASSOCIATIONS OF SEXUAL DYSFUNCTION WITH LOCALIZED AND ADVANCED PROSTATE CANCER: A CASE-CONTROL STUDY NESTED WITHIN THE UK POPULATION-BASED PROTECT (PROSTATE TESTING FOR CANCER AND TREATMENT) STUDY
-н: Collin, S, зэрэг
Хэвлэсэн: (2009)

ASSOCIATION OF ANTHROPOMETRIC AND LIFESTYLE FACTORS WITH PROSTATE SPECIFIC ANTIGEN (PSA) TRAJECTORIES IN MEN WITH LOCALISED PROSTATE CANCER UNDERGOING ACTIVE MONITORING
-н: Burton, A, зэрэг
Хэвлэсэн: (2011)

Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen
-н: Harrison, S, зэрэг
Хэвлэсэн: (2020)

The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group.
-н: Vickers, A, зэрэг
Хэвлэсэн: (2010)

Associations of sexual dysfunction symptoms with PSA-detected localised and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study.
-н: Collin, S, зэрэг
Хэвлэсэн: (2009)

Latest results from the UK trials evaluating prostate cancer screening and treatment: the CAP and ProtecT studies.
-н: Lane, J, зэрэг
Хэвлэсэн: (2010)

Associations of folate, vitamin B12, homocysteine, and folate-pathway polymorphisms with prostate-specific antigen velocity in men with localized prostate cancer.
-н: Collin, S, зэрэг
Хэвлэсэн: (2010)

Association of diabetes mellitus with prostate cancer: nested case-control study (Prostate testing for cancer and treatment study).
-н: Turner, E, зэрэг
Хэвлэсэн: (2011)

Development of a new method for monitoring prostate-specific antigen changes in men with localised prostate cancer: a comparison of observational cohorts.
-н: Tilling, K, зэрэг
Хэвлэсэн: (2010)

Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screening.
-н: Oliver, SE, зэрэг
Хэвлэсэн: (2004)

Investigating the prostate specific antigen, body mass index and age relationship: is an age-BMI-adjusted PSA model clinically useful?
-н: Harrison, S, зэрэг
Хэвлэсэн: (2016)

Detection of prostate cancer in unselected young men: prospective cohort nested within a randomised controlled trial.
-н: Lane, J, зэрэг
Хэвлэсэн: (2007)

Measurement of the insulin-like growth factor (IGF)-axis does not enhance the specificity of PSA-based prostate cancer screening.
-н: Oliver, SE, зэрэг
Хэвлэсэн: (2002)

Screening for prostate cancer. The case against.
-н: Donovan, J, зэрэг
Хэвлэсэн: (2005)

Experiences and decision processes during PSA testing and prostate biopsy: A qualitative study
-н: Avery, K, зэрэг
Хэвлэсэн: (2007)

Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study).
-н: Donovan, J, зэрэг
Хэвлэсэн: (2003)

10-year outcomes in localized prostate cancer.
-н: Hamdy, F, зэрэг
Хэвлэсэн: (2017)

THE PROTECT TRIAL - EVALUATING THE EFFECTIVENESS OF TREATMENTS FOR CLINICALLY LOCALISED PROSTATE CANCER
-н: Lane, J, зэрэг
Хэвлэсэн: (2009)

Prostate cancer: screening approaches.
-н: Donovan, J, зэрэг
Хэвлэсэн: (2005)